Clinical TrialsSearch results
Number of results: 498
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18
Other
- Dose-adjusted EPOCH therapy for the previously untreated patients of advanced peripheral T-cell lymphoma
- previouly untreated advanced stage peripheral T-cell lymphoma
- West Japan Hematology Oncology Group
- 2007-09-22
Other
- Effect of early tongue training on oral function for the young older (Early tongue training using medical Pekopanda)
- Preservation and improvement of tongue pressure
- Tsuga Kazuhiro
- 2022-09-13
Other
- Validation of efficacy of cervical cerclage in patients with short cervical length
- Pregnant women with subclinical infection and cervical length 25 mm as diagnosed by transvaginal ultrasonography in a maternity health examination conducted during the second trimester of pregnancy (between week 16 day 0 and week 26 day 6 of gestation)
- Japan Organization of Prevention of Preterm Delivery
- 2009-04-20
Other
- Verification of the efficacy of intravaginal ulinastatin administration in patients with cervical shortening
- Pregnant women with subclinical infection and cervical length 25 mm as diagnosed by transvaginal ultrasonography in a maternity health examination conducted during the second trimester of pregnancy (between week 16 day 0 and week 26 day 6 of gestation)
- Japan Organization of Prevention of Preterm Delivery
- 2009-04-15
Other
- Randomized Phase III Study of Adjuvant Endocrine-Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients who Responded to Neoadjuvant Letrozole
- postmenopausal primary breast cancer
- NEOS executive committee
- 2008-03-20
Other
- Assessment of the Efficacy of Preoperative Endocrine Therapy of Letrozole in Postmenopausal Patients with Hormone-sensitive Breast cancer of Stage IIA to IIB
- Postmenopausal Breast Cancer
- Department of Breast and Thyroid Surgery, Kawasaki Medical School
- 2007-11-08
Other
- Assessment of the efficacy of the use of zoledronic acid in the prevention of aromatase inhibitor-associated bone loss in postmenopausal women with hormone receptor-positive breast cancer who received letrozole as adjuvant therapy
- Postmenopausal Breast Cancer
- Cancer Institute Hospital
- 2008-03-29